US Health Alerts 2025: Influenza H3N2, Measles Outbreak, Mpox Case, and New Vaccine Recommendations Spark Nationwide Concern
カートのアイテムが多すぎます
ご購入は五十タイトルがカートに入っている場合のみです。
カートに追加できませんでした。
しばらく経ってから再度お試しください。
ウィッシュリストに追加できませんでした。
しばらく経ってから再度お試しください。
ほしい物リストの削除に失敗しました。
しばらく経ってから再度お試しください。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
-
ナレーター:
-
著者:
このコンテンツについて
Measles continues to pose a serious threat, with ProMED reporting 148 confirmed cases in South Carolina alone, along with additional cases documented in South Dakota and North Carolina. Listeners should be aware that measles exposure has occurred at multiple airports and on flights, suggesting potential for continued spread in transportation hubs.
Pertussis, commonly known as whooping cough, remains active in Tennessee and Texas according to health surveillance data. ProMED also confirms that Hansen's disease has been identified in Florida, marking an important development for a condition that requires specific clinical attention and contact investigation.
A critical development involves mpox, with ProMED documenting the first confirmed 2025 case in El Paso, Texas. This represents an important epidemiological marker as the nation continues monitoring mpox transmission patterns.
Respiratory syncytial virus, or RSV, continues circulating domestically, though international cases have shown serious complications including respiratory distress syndrome.
Additionally, the CDC Advisory Council on Immunization Practices recently voted to eliminate long-standing recommendations for hepatitis B vaccines for newborns, according to reporting from NOTUS and Undark. This represents a significant shift in pediatric immunization guidance that parents and healthcare providers should be aware of as they make vaccination decisions for infants.
Thank you for tuning in. Be sure to subscribe for continued health updates and information. This has been a Quiet Please production. For more, check out quietplease.ai.
For more http://www.quietplease.ai
Get the best deals https://amzn.to/3ODvOta
This content was created in partnership and with the help of Artificial Intelligence AI
まだレビューはありません